Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,130 public trials 394 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

NCT02435173

Conditions
Activated PI3K-delta Syndrome, Common Variable Immunodeficiency, Common Variable Immunodeficiency (CVID), APDS / PASLI, +2 more
Locations
  • National Institute of Health NIH Bethesda, Maryland, United States
  • Novartis Investigative Site Minsk, Belarus
  • Novartis Investigative Site Prague, Czechia
  • Novartis Investigative Site Dresden, Germany
View Trial Details
Completed

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

NCT00820846

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

NCT02852005

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

NCT00301184

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
View Trial Details
Completed

Positive Health Check Evaluation Trial

NCT03292913

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Hillsborough County Health Department Tampa, Florida, United States
  • Atlanta VA Medical Center Atlanta, Georgia, United States
  • Crescent Care New Orleans, Louisiana, United States
  • Rutgers Infectious Disease Practice Newark, New Jersey, United States
View Trial Details
Completed

Comparison of Men's Prevention Apps to Research Efficacy

NCT03965221

Conditions
Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +21 more
Locations
  • University of South Florida, Infectious Diseases Tampa, Florida, United States
  • PRISM Health Atlanta, Georgia, United States
  • Ayar @ Core Chicago, Illinois, United States
  • Fenway Health Center Boston, Massachusetts, United States
View Trial Details

Related conditions